Benjamin Ebert
16Patents
2h-index
24Co-inventors
50Inventor score
Filing activity: Apr 20, 2012 → Mar 7, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9974289B2 | Knock-in rodent comprising a mutation in an endogenous CRBN locus and methods of use thereof | Physics | 2 | Active |
| US10334829B2 | IMiD screening methods IMiD-sensitive cells with mutant CRBN | Physics | 2 | Active |
| US11168345B2 | Methods of identifying a polypeptide target for degradation by a modulator of CRBN | Chemistry; Metallurgy | 2 | Active |
| US11168369B2 | Method of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease | Physics | 1 | Active |
| US11304938B2 | Compositions and methods for treating chemotherapy resistant cancer | Human Necessities | 1 | Active |
| US9164094B2 | Biomarkers to identify HIV-specific T-cell subsets | Physics | 0 | Active |
| US10711308B2 | Mutation signatures for predicting the survivability of myelodysplastic syndrome subjects | Chemistry; Metallurgy | 0 | Active |
| US12049482B2 | Molecular switch-mediated control of engineered cells | Chemistry; Metallurgy | 0 | Active |
| US11785925B2 | Disease biomarkers and treatment methods related thereto | Physics | 0 | Active |
| US11015223B2 | Methods for determining response to a hypomethylating agent | Chemistry; Metallurgy | 0 | Active |
| US8828965B2 | MiR-150 for the treatment of blood disorders | Chemistry; Metallurgy | 0 | Active |
| US11426405B2 | Inhibition of JAK-STAT signaling inhibits formation of neutrophil extracellular traps (NETs) | Chemistry; Metallurgy | 0 | Active |
| US11459613B2 | Methods of characterizing resistance to modulators of Cereblon | Chemistry; Metallurgy | 0 | Active |
| US12201620B2 | Compositions and methods for treating chemotherapy resistant cancer | Human Necessities | 0 | Active |
| US8530443B2 | miR-150 for the treatment of blood disorders | Chemistry; Metallurgy | 0 | Active |
| US11788144B2 | Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.